Effects of Dose Titration on Tolerability and Efficacy of Interferon Beta-1b in People with Multiple Sclerosis

By Wroe SJ  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 309-318

Field House Publishing

Access to resources Recommend Favorite

Subcutaneous Recombinant Interferon-β-1a (Rebif®): A Review of its Use in the Treatment of Relapsing Multiple Sclerosis

By Sanford Mark   Lyseng-Williamson Katherine A.  

Drugs, Vol. 71, Iss. 14, 2011-10 ,pp. : 1865-1891

Adis International

Access to resources Recommend Favorite

Dose and Frequency of Administration of Interferon- Affect its Efficacy in Multiple Sclerosis

By Sharief M.K.  

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 551-559

Adis International

Access to resources Recommend Favorite

Interferon-β_1b for the treatment of multiple sclerosis

By Lam Sum   Wang Shan   Gottesman Malcolm  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β_1b in the treatment of multiple sclerosis

By Río Jordi   Montalban Xavier  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite